bi 425809
Small moleculeexperimental
Clinical trial activity
28 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
21
Phase 2
7
Phase 3
4
Phase 4
0
Earliest trial started Mar 1, 2014 (NCT02068690)
Timeline
Indications
Mechanism of action
- Glycine transporter 1INHIBITOR
SLC6A9 inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
C[C@@H](Oc1ccc(S(C)(=O)=O)cc1C(=O)N1C[C@@H]2C[C@]2(c2cc(C(F)(F)F)on2)C1)C(F)(F)F- Mol. weight
- 512.43 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5314576 ↗
Also known as
- bi 425809
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06070597 | Phase 1 | Jan 25, 2024 | Boehringer Ingelheim |
| NCT05731895 | Phase 1 | Mar 8, 2023 | Boehringer Ingelheim |
| NCT05723874 | Phase 1 | Mar 6, 2023 | Boehringer Ingelheim |
| NCT05718843 | Phase 1 | Feb 1, 2023 | Boehringer Ingelheim |
| NCT05613777 | Phase 1 | Nov 24, 2022 | Boehringer Ingelheim |
| NCT05347004 | Phase 1 | Oct 25, 2022 | Boehringer Ingelheim |
| NCT05258110 | Phase 1 | Mar 18, 2022 | Boehringer Ingelheim |
| NCT05211947 | Phase 3 | Mar 3, 2022 | Boehringer Ingelheim |
| NCT05076409 | Phase 1 | Oct 19, 2021 | Boehringer Ingelheim |
| NCT04860830 | Phase 3 | Jun 18, 2021 | Boehringer Ingelheim |
| NCT04846868 | Phase 3 | Jun 16, 2021 | Boehringer Ingelheim |
| NCT04846881 | Phase 3 | Jun 7, 2021 | Boehringer Ingelheim |
| NCT04602221 | Phase 1 | Dec 1, 2020 | Boehringer Ingelheim |
| NCT03988803 | Phase 1 | Jul 5, 2019 | Boehringer Ingelheim |
| NCT03859973 | Phase 2 | Apr 15, 2019 | Boehringer Ingelheim |
| NCT03905096 | Phase 1 | Apr 12, 2019 | Boehringer Ingelheim |
| NCT03817476 | Phase 1 | Feb 11, 2019 | Boehringer Ingelheim |
| NCT03783000 | Phase 1 | Jan 15, 2019 | Boehringer Ingelheim |
| NCT03654170 | Phase 1 | Sep 11, 2018 | Boehringer Ingelheim |
| NCT03082183 | Phase 1 | Mar 28, 2017 | Boehringer Ingelheim |
Showing 20 of 28 trials
Page 1 / 2
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boehringer Ingelheim | For profit | 28 | 28 | 3 | 2014 |
1 organizations
Page 1 / 1